Paola Luciani

Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Pharmaceutics

Journal of materials chemistry. B

Cancers

Drug delivery and translational research

University of Bern

Università degli Studi di Roma La Sapienza (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bern Apr 01 2019

Switzerland

Full Professor :: Department of Chemisty and Biochemistry

Friedrich-Schiller-Universität Jena - Mar 31 2019

Germany

Professor :: Pharmaceutical Technology

Swiss Federal Institute of Technology in Zurich

Switzerland

Group Leader :: Institute of Pharmaceutical Sciences

Swiss Federal Institute of Technology in Zurich

Switzerland

Postdoctoral scientist :: Institute of Pharmaceutical Sciences

Università degli Studi di Firenze

Italy

Postdoctoral fellow :: Chemistry

Education History

Università degli Studi di Roma La Sapienza Oct 01 2002 - Feb 16 2006

Italy

PHD :: Chemistry

Università degli Studi di Roma La Sapienza

Italy

MSC :: Chemistry

Publications

Rafaela Gazzi, Rita Gelli, Simone Aleandri, Marianna Carone, Paola Luciani
Bioinspired and bioderived nanomedicine for inflammatory bowel disease. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 16 (4) (2024)
Marianna Carone, Marianne Rebecca Spalinger, Robert A Gaultney, Raffaele Mezzenga, Kristýna Hlavačková, Aart Mookhoek, Philippe Krebs, Gerhard Rogler, Paola Luciani, Simone Aleandri
Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitis. Nature communications 14 (1) (2023)
Remo Eugster, Aymar Abel Ganguin, Amirmohammad Seidi, Simone Aleandri, Paola Luciani
3D printing injectable microbeads using a composite liposomal ink for local treatment of peritoneal diseases. Drug delivery and translational research (2023)
Aymar Abel Ganguin, Ivo Skorup, Sebastian Streb, Alaa Othman, Paola Luciani
Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics Against Chronic Liver Disease. Advanced healthcare materials (2023)
Cristina Zivko, Kathrin Fuhrmann, Molly M Stevens, Paola Luciani
Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments. Communications biology 5 (1) (2022)
Oumar Elzenaty, Paola Luciani, Simone Aleandri
A lipidic mesophase with tunable release properties for the local delivery of macromolecules: the apoferritin nanocage, a case study. Journal of materials chemistry. B 10 (20) (2022)
Florian Weber, Tommaso Casalini, Gina Valentino, Lorine Brülisauer, Nico Andreas, Andreas Koeberle, Thomas Kamradt, Alessandro Contini, Paola Luciani
Targeting transdifferentiated hepatic stellate cells and monitoring the hepatic fibrogenic process by means of IGF2R-specific peptides designed in silico. Journal of materials chemistry. B 9 (8) (2021)
Nagjie Alijaj, Sandrine Moutel, Zelia L Gouveia, Maxim Gray, Maurizio Roveri, Dzhangar Dzhumashev, Florian Weber, Gianmarco Meier, Paola Luciani, Jochen K Rössler, Beat W Schäfer, Franck Perez, Michele Bernasconi
Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers 12 (11) (2020)
Lisa Rahnfeld, Paola Luciani
Injectable Lipid-Based Depot Formulations: Where Do We Stand? Pharmaceutics 12 (6) (2020)
Gina Valentino, Cristina Zivko, Florian Weber, Lorine Brülisauer, Paola Luciani
Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics 11 (12) (2019)

Paola Luciani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paola Luciani